Epocrates Partnered With ScriptSave for Drug Pricing

The integration brings real-time cost data to clinicians to help manage patient prescription adherence.

Updated on Sept. 23, 2026 in Couponing

Isometric editorial illustration of a single prescription bottle on a desk, representing the integration of drug pricing tools for clinicians. — Epocrates has partnered with ScriptSave to integrate real-time drug pricing data into its platform, helping clinicians manage patient prescription costs at the point of care. AI Illustration. Upload story photo >

Live Poll

Would knowing exact drug costs during your doctor's visit help you afford your prescriptions?

Epocrates has partnered with ScriptSave to embed real-time drug pricing data directly into its clinical prescribing platform. This integration allows healthcare providers to view cost information and savings opportunities during the treatment decision process.

Why it matters

The collaboration aims to reduce operational friction for clinicians while helping them manage prescriptions within a patient's budget. This is vital as 43 percent of US adults reported failing to take medications as directed due to costs in the last 12 months.

Epocrates supports over 1 million registered healthcare professionals who perform 400,000 daily drug lookups. The platform integration is expected to increase new-to-brand prescriptions by 15 percent to 25 percent.

The players

Epocrates

Epocrates is a clinical information platform that provides drug, disease, and diagnostic data to over 1 million healthcare professional users.

ScriptSave

ScriptSave is a healthcare technology company that provides pharmacy benefit services and real-time drug pricing solutions.

The details

Clinicians can now access pricing data natively, enabling them to evaluate affordability before finalizing a prescription. Epocrates plans to expand the tool in future phases with faster data refreshes and direct patient resources.

Epocrates became the exclusive reseller of ConnectiveRx's ScriptGuide in 2021.
Enhanced ACA premium tax credits expired at the end of 2025.
Surescripts launched Script Corner in January 2026.
Medicare's Part D Premium Stabilization Demonstration concludes at the end of the 2026 contract year.

Culture Shift

This integration reflects a broader shift toward price transparency in healthcare as public assistance programs like the Medicare Part D Premium Stabilization Demonstration reach their conclusion. It signals a move away from reliance on government subsidies and toward provider-led cost management tools.

Patients may notice their doctors discussing more affordable prescription alternatives during office visits. These discussions aim to help users adhere to treatment plans by addressing cost barriers at the point of care.

The takeaway

Clinicians are increasingly leveraging data tools to bridge the gap between treatment necessity and patient affordability. Using these resources can help patients avoid the financial stress that often leads to non-adherence to prescribed medical therapies.